Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Smoked Cannabis for Chronic, Treatment-Resistant PTSD in Veterans
NCT02759185Phase 2Completed
- Sponsor
- Multidisciplinary Association for Psychedelic Studies
- Start
- Jan 2017
- Primary completion
- Nov 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dronabinol, cannabidiol in post-traumatic stress disorder (PTSD), sponsored by Multidisciplinary Association for Psychedelic Studies. Started Jan 2017; status: completed.
02
Drugs
dronabinolcannabidiol
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on NCT02759185.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02759185.